Related Experiment Video
Updated: Mar 26, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Legionellosis in Transplantation
Shobini Sivagnanam1, Steven A Pergam2,3,4
1Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, E4-100, Seattle, WA, 98109, USA.
Legionella bacteria pose a growing risk to transplant patients, causing severe illness. Current diagnostic tests miss some Legionella types, highlighting the need for better management and prevention strategies.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Microbiology
Background:
- Legionella species are opportunistic pathogens increasingly affecting hematopoietic stem cell and solid organ transplant recipients.
- These infections lead to significant morbidity and mortality in immunocompromised patients.
- Clinical presentation and radiological findings often mimic other infections, complicating diagnosis.
Purpose of the Study:
- To review the epidemiology, clinical features, diagnostic challenges, treatment, and prevention of Legionella infections in transplant recipients.
- To address the lack of transplant-specific guidelines for managing and preventing these infections.
- To highlight the rising risk due to evolving transplant management and Legionella epidemiology.
Main Methods:
- Literature review of Legionella infections in transplant populations.
- Analysis of diagnostic challenges, including limitations of urinary antigen tests for non-pneumophila species.
- Synthesis of current treatment options and preventive strategies.
Main Results:
- Legionella infections present diagnostic challenges in transplant patients, especially non-pneumophila species.
- The risk of Legionella exposure may be increasing in this population.
- There is a critical need for evidence-based, transplant-specific management guidelines.
Conclusions:
- Legionella infections represent a significant and under-recognized threat to transplant recipients.
- Improved diagnostic approaches and tailored preventive measures are essential.
- Development of specific clinical guidelines is crucial for optimizing patient outcomes.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses

